Every trade that managers of Autonomix Medical, Inc. disclose to SEC (Form 4) is tracked on this page. In the past year (24 October 2025 to 24 October 2026), 4 filings came from 4 insiders.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
For context, the typical company on the same exchange (median of 5,811 companies) published 19 filings over the same period, against 4 filings here. For the fiscal year to 31 March 2026, the annual 10-K puts net income at -16.7 m USD.
There has been no open-market purchase by an insider of Autonomix Medical, Inc. for at least a year. Filings reach the SEC (Form 4) feed a median of 5 days after the trade. Section 16 rules allow two business days to file each Form 4.
In the same market, recent insider purchases at GameStop Corp. and Heico Corp also feature in our signals. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
FY ended March 2026 · cache
4 of 4 declarations
Autonomix Medical, Inc. is a company focused on developing innovative medical technologies. It aims to enhance healthcare through autonomous solutions.
Purchases our model currently ranks for the recommendations list.
All recommendations